The topics page enables quick access to all resource types on
the platform, organized by relevance to your topic.
Popular Searches
Featured Topics
Featured Topics
831 - 840 of 5695 Topics
-
Publication
Key challenges in bringing CRISPR-mediated somatic cell therapy into the clinic
Genome Med -
Publication
Gene patents and personalized medicine – what lies ahead?
Genome MedicineDuke University Center for Public Genomics. Grant number(s): P50HG003391 -
Publication
Gene patents and personalized medicine - What lies ahead?
Genome MedDuke University Center for Public Genomics. Grant number(s): P50HG003391 -
Publication
The ethics of genetic testing for inherited cancer- predisposing genes
Journal of the Advanced Practitioner in Oncology -
Publication
Regulatory considerations for novel gene therapy products: A review of the process leading to the first clinical lentiviral vector
Human Gene TherapyDigital citation created by the Bioethics Research Library, Georgetown University, for the National Information Resource on Ethics and Human Genetics, a project funded by the United States National… -
Publication
The ethics of crowdfunding in paediatric neurology
Developmental Medicine & Child Neurology -
Publication
Human gene therapy patents issued in the United States: July 1, 1995 to June 30, 1996
Human Gene TherapyDigital citation created by the Bioethics Research Library, Georgetown University, for the National Information Resource on Ethics and Human Genetics, a project funded by the United States National… -
Publication
Pathways across the valley of death: Novel intellectual property strategies for accelerated drug discovery
Cambridge University PressDuke University Center for Public Genomics. Grant number(s): P50HG003391 -
Publication
Ethical aspects of hemophilia gene therapy: A qualitative interview study with stakeholders
Research Practice in Thrombosis and Haemostasis -
Grant Abstract
Economic Evaluations of Emerging Genomic Tests for Early Stage Breast Cancer
Emerging medical technologies are substantially improving our health care options, but often at considerable added cost. Cost-effectiveness and affordability are described as the fourth and fifth…- Clinical
- cost
- cost effectiveness
- Early treatment
- Economics